Vasoconstrictor responses are normal but prostanoid-mediated vasodilatation is enhanced in human cirrhotic mesenteric arteries

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 8, 2005, Pages 1158-1164

  Vaughan, Rhys B ^a   Angus, James A ^b   Angus, Peter W ^a  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Hyperdynamic circulation; Liver transplantation; Mulvany myograph

Indexed keywords

ACETYLCHOLINE; METHOXAMINE; NITRIC OXIDE; NORADRENALIN; POTASSIUM; PROSTANOID; SUBSTANCE P; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; ENDOTHELIUM; FEMALE; HUMAN; IN VIVO STUDY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MESENTERIC ARTERY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VASODILATATION;

EID: 27744521529     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03946.x     Document Type: Article

References (38)

1. Murray JF, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am. J. Med. 1958; 24: 358-67.
2. Kotelanski B, Groszmann RJ, Cohn JN. Circulation times in the splanchnic and hepatic beds in alcoholic liver disease. Gastroenterology 1972; 63: 102-11.
3. Groszmann RJ. Hyperdynamic state in chronic liver diseases. J. Hepatol. 1993; 17: S38-40.
4. Floras JS, Legault L, Morali GA, Hara K, Blendis LM. Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings. Ann. Intern. Med. 1991; 114: 373-80.
5. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis, a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-7.
6. Moller S, Bendtsen F, Henriksen JH. Vasoactive substances in the circulatory dysfunction of cirrhosis. Scand. J. Clin. Lab. Invest. 2001; 61: 421-9.
7. Hadoke PW, Dillon JF, John TG, Walker SW, Hayes PC, Williams BC. Contractile response of isolated human hepatic arteries to alpha-adrenoceptor agonists is not impaired in patients with cirrhosis. Clin. Sci. (Colch) 1998; 95: 505-11.
8. Islam MZ, Williams BC, Madhavan KK, Hayes PC, Hadoke PW. Selective alteration of agonist-mediated contraction in hepatic arteries isolated from patients with cirrhosis. Gastroenterology 2000; 118: 765-71.
9. Heller J, Schepke M, Gehnen N et al. Altered adrenergic responsiveness endothelium-denuded hepatic arteries portal veins patients with cirrhosis. Gastroenterology 1999; 116: 387-93.
10. Schepke M, Heller J, Paschke S et al. Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: evidence for a receptor-specific mechanism. Hepatology 2001; 34: 884-8.
11. Cahill PA, Redmond EM, Sitzmann JV. Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol. Ther. 2001; 89: 273-93.
12. Weigert AL, Martin PY, Niederberger M et al. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats. Hepatology 1995; 22: 1856-62.
13. Claria J, Jimenez W, Ros J et al. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites [see comments]. Hepatology 1994; 20: 1615-21.
14. Castro A, Jimenez W, Claria J et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide [see comments]. Hepatology 1993; 18: 367-72.
15. Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993; 104: 1750-4.
16. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 2002; 35: 478-91.
17. Angus JA, Broughton A, McPherson GA. Membrane potential and contractility responses to acetylcholine and other vasoconstrictor stimuli in human small coronary arteries. In: Mulvany MJ, Aalkjaer C, Heagerty AM, N.C.B. N, Trandgaard S, eds. Resistance Arteries, Structure and Function. Amsterdam: Elsevier. (International Congress Series), 1991; 255-60.
18. MacGilchrist AJ, Sumner D, Reid JL. Impaired pressor reactivity in cirrhosis: evidence for a peripheral vascular defect. Hepatology 1991; 13: 689-94.
19. Ryan J, Sudhir K, Jennings G, Esler M, Dudley F. Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis. Gastroenterology 1993; 105: 1167-72.
20. Groeneveld ABJ. Pulmonary artery catheterization. In: Webb AR, Shapiro MJ, Singer M, Suter PM, eds. Oxford Textbook of Critical Care. Oxford: Oxford University Press, 1999; 1094-8.
21. Angus JA, Wright CE. Techniques to study the pharmacodynamics of isolated large and small blood vessels. J. Pharmacol. Toxicol. Methods 2000; 44: 395-407.
22. Battaglia SE, Jones RM, Angus JA, Smallwood RA, Angus PW. Altered acetylcholine responsiveness in human 'cirrhotic' intrahepatic arteries (Abstract). Hepatology 1996; 24: 143A.
23. Angus JA, Jennings GL, Sudhir K. Enhanced contraction to noradrenaline, serotonin and nerve stimulation but normal endothelium-derived relaxing factor response in skin small arteries in human primary hypertension. Clin. Exp. Pharmacol. Physiol. Suppl. 1992; 19: 39-47.
24. Angus JA, Cocks TM, McPherson GA, Broughton A. The acetylcholine paradox: a constrictor of human small coronary arteries even in the presence of endothelium. Clin. Exp. Pharmacol. Physiol. 1991; 18: 33-6.
25. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation 1995; 92: 3337-49.
26. Chen G, Suzuki H. Some electrical properties of the endothelium-dependent hyperpolarization recorded from rat arterial smooth muscle cells. J. Physiol. 1989; 410: 91-106.
27. Hadoke PW, Hayes PC. In vitro evidence for vascular hyporesponsiveness in clinical and experimental cirrhosis. Pharmacol. Ther. 1997; 75: 51-68.
28. Hughes AD, Thorn SA, Martin GN et al. Size and site-dependent heterogeneity of human vascular responses in vitro. J. Hypertens. Suppl. 1988; 6: S173-5.
29. Nielsen H, Mortensen FV, Mulvany MJ. Differential distribution of postjunctional alpha 2 adrenoceptors in human omental small arteries. J. Cardiovasc. Pharmacol. 1990; 16: 34-40.
30. Fukui D, Chiba S. Existence of alpha-adrenoceptor subtypes in isolated human gastroepiploic and omental arteries. Circ. J. 2003; 67: 259-62.
31. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 1990; 323: 27-36.
32. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
33. MacIntyre DE, Pearson JD, Gordon JL. Localisation and stimulation of prostacyclin production in vascular cells. Nature 1978; 271: 549-51.
34. Brandes RP, Schmitz-Winnenthal FH, Feletou M et al. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc. Natl. Acad. Sci. USA 2000; 97: 9747-52.
35. Haynes WG. Endothelins as regulators of vascular tone in man. Clin. Sci. (Colch) 1995; 88: 509-17.
36. Aalkjaer C, Mulvany MJ. Functional and morphological properties of human omental resistance vessels. Blood Vessels 1981; 18: 233-44.
37. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 1977; 41: 19-26.
38. Bruix J, Bosch J, Kravetz D, Mastai R, Rodes J. Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver. Gastroenterology 1985; 88: 430-5.